dextroamphetamine has been researched along with Amphetamine-Related Disorders in 74 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
Amphetamine-Related Disorders: Disorders related or resulting from use of amphetamines.
| Excerpt | Relevance | Reference |
|---|---|---|
| "One of the most devastating consequences of methamphetamine abuse is increased risk of psychosis." | 3.83 | BDNF-Deficient Mice Show Reduced Psychosis-Related Behaviors Following Chronic Methamphetamine. ( Halberstadt, AL; Manning, EE; van den Buuse, M, 2016) |
| "At follow-up, degree of methamphetamine dependence was significantly lower in the dexamphetamine group (P = 0." | 2.75 | Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence. ( Cahill, S; Harrison, S; Longo, M; Smout, M; White, JM; Wickes, W, 2010) |
| "Tesofensine is a (triple) reuptake inhibitor of noradrenaline, dopamine, and serotonin that is in development for the treatment of obesity." | 2.75 | Subjective and objective effects of the novel triple reuptake inhibitor tesofensine in recreational stimulant users. ( Chakraborty, B; Manniche, PM; Meier, D; Schoedel, KA; Sellers, EM, 2010) |
| "Disulfiram did enhance some of the subjective effects of dextroamphetamine including ratings of "high," "anxious," "bad drug effects," "want more drug" and "drug liking" and was also associated with decreased performance in the SART test." | 2.73 | Disulfiram enhances subjective effects of dextroamphetamine in humans. ( Hill, K; Kosten, T; Poling, J; Sewell, A; Sofuoglu, M; Waters, A, 2008) |
| "Reduced street amphetamine use and amphetamine dependence was observed both in subjects prescribed dexamphetamine and subjects receiving counselling only." | 2.70 | Pilot randomized controlled study of dexamphetamine substitution for amphetamine dependence. ( Dolan, K; Hall, W; Lewis, J; Mattick, RP; Shearer, J; Van Beek, I; Wodak, A, 2001) |
| "Amphetamine dependence is relatively common in Sweden and it is the most frequently used substance among patients with intravenous drug abuse." | 2.53 | [Substitution therapy tested against amphetamine dependence]. ( Bloniecki Kallio, V; Franck, J; Guterstam, J, 2016) |
| "Amphetamine was discovered over 100 years ago." | 2.49 | Amphetamine, past and present--a pharmacological and clinical perspective. ( Gosden, J; Heal, DJ; Nutt, DJ; Smith, SL, 2013) |
| "Amphetamine dependence is a public health problem with medical, psychiatric, cognitive, legal and socioeconomic consequences." | 2.49 | Efficacy of psychostimulant drugs for amphetamine abuse or dependence. ( Capellà, D; Castells, X; Farre, M; Pérez-Mañá, C; Torrens, M, 2013) |
| " Rats received an escalating (1-8 mg/kg) dosing regimen of d-amphetamine (twice daily, i." | 1.35 | A sensitizing d-amphetamine regimen induces long-lasting spinophilin protein upregulation in the rat striatum and limbic forebrain. ( Boikess, SR; Marshall, JF, 2008) |
| "Low amphetamine doses have been associated with enhanced performance in studies of sleep-deprived subjects." | 1.35 | [Driving under the influence of amphetamine and metamphetamine]. ( Lia, K; Slørdal, L; Spigset, O, 2009) |
| "Pretreatment with baclofen produced dose-dependent reductions in responding for dAMPH under both the FR and PR schedules, and attenuated dAMPH-induced increases in DA levels in the NAc." | 1.33 | Attenuation of d-amphetamine self-administration by baclofen in the rat: behavioral and neurochemical correlates. ( Ahn, S; Brebner, K; Phillips, AG, 2005) |
| " Changing the unit dose produced a characteristic U-shaped dose-response curve." | 1.30 | RU-24969 disrupts d-amphetamine self-administration and responding for conditioned reward via stimulation of 5-HT1B receptors. ( Fletcher, PJ; Korth, KM, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (4.05) | 18.2507 |
| 2000's | 32 (43.24) | 29.6817 |
| 2010's | 37 (50.00) | 24.3611 |
| 2020's | 2 (2.70) | 2.80 |
| Authors | Studies |
|---|---|
| Thompson, RG | 1 |
| Oliveto, A | 1 |
| Thostenson, JD | 1 |
| Wilson, MP | 1 |
| McGaugh, J | 1 |
| Mancino, MJ | 1 |
| Acosta, DL | 1 |
| Fair, CN | 1 |
| Gonzalez, CM | 1 |
| Iglesias, M | 1 |
| Maldonado, N | 1 |
| Schenkman, N | 1 |
| Valle, SM | 1 |
| Velez, JL | 1 |
| Mejia, L | 1 |
| McNealy, KR | 1 |
| Ramsay, ME | 1 |
| Barrett, ST | 1 |
| Bevins, RA | 1 |
| Weafer, J | 2 |
| Lyon, N | 1 |
| Hedeker, D | 1 |
| de Wit, H | 4 |
| Crane, NA | 1 |
| Gorka, SM | 1 |
| Langenecker, SA | 1 |
| Phan, KL | 1 |
| Lee, NK | 1 |
| Jenner, L | 1 |
| Harney, A | 1 |
| Cameron, J | 1 |
| Heal, DJ | 1 |
| Smith, SL | 1 |
| Gosden, J | 1 |
| Nutt, DJ | 1 |
| Pérez-Mañá, C | 1 |
| Castells, X | 1 |
| Torrens, M | 1 |
| Capellà, D | 1 |
| Farre, M | 1 |
| Murray, RC | 2 |
| Hebbard, JC | 1 |
| Logan, AS | 1 |
| Vanchipurakel, GA | 1 |
| Gilbert, YE | 1 |
| Horner, KA | 2 |
| Pike, E | 1 |
| Stoops, WW | 4 |
| Hays, LR | 1 |
| Glaser, PE | 2 |
| Rush, CR | 4 |
| Wagner, D | 1 |
| Koester, P | 1 |
| Becker, B | 1 |
| Gouzoulis-Mayfrank, E | 1 |
| Hellmich, M | 1 |
| Daumann, J | 1 |
| Chiu, HF | 1 |
| Cheng, JK | 1 |
| Lin, PH | 1 |
| Chang, JC | 1 |
| Chen, IM | 1 |
| Lin, CI | 1 |
| Chang, WP | 1 |
| Lin, CH | 1 |
| Schrantee, A | 2 |
| Václavů, L | 1 |
| Heijtel, DF | 1 |
| Caan, MW | 1 |
| Gsell, W | 1 |
| Lucassen, PJ | 1 |
| Nederveen, AJ | 1 |
| Booij, J | 2 |
| Reneman, L | 2 |
| Taepavarapruk, P | 1 |
| Butts, KA | 1 |
| Phillips, AG | 4 |
| Kaland, ME | 1 |
| Klein-Schwartz, W | 1 |
| Yarosh, HL | 1 |
| Meda, SA | 1 |
| Hart, AB | 1 |
| Pearlson, GD | 1 |
| Miller, ME | 1 |
| Badger, GJ | 1 |
| Heil, SH | 1 |
| Higgins, ST | 1 |
| Sigmon, SC | 1 |
| Fuller, JJ | 1 |
| Ferguson, B | 1 |
| Stoffers, D | 1 |
| Rombouts, S | 1 |
| Manning, EE | 1 |
| Halberstadt, AL | 1 |
| van den Buuse, M | 1 |
| Bloniecki Kallio, V | 1 |
| Guterstam, J | 1 |
| Franck, J | 4 |
| Eggleston, W | 1 |
| Stork, C | 1 |
| Nesbit, MO | 1 |
| Dias, C | 1 |
| Boikess, SR | 1 |
| Marshall, JF | 1 |
| Lia, K | 1 |
| Spigset, O | 1 |
| Slørdal, L | 1 |
| Häggkvist, J | 2 |
| Lindholm, S | 2 |
| Gipson, CD | 2 |
| Bardo, MT | 3 |
| Longo, M | 1 |
| Wickes, W | 1 |
| Smout, M | 1 |
| Harrison, S | 1 |
| Cahill, S | 1 |
| White, JM | 1 |
| Jun, A | 1 |
| McCloskey, M | 1 |
| Palmer, AA | 1 |
| Björkholm, C | 1 |
| Steensland, P | 1 |
| Schilström, B | 1 |
| Schoedel, KA | 1 |
| Meier, D | 1 |
| Chakraborty, B | 1 |
| Manniche, PM | 1 |
| Sellers, EM | 1 |
| Sevak, RJ | 1 |
| Zhornitsky, S | 1 |
| Potvin, S | 1 |
| Stip, E | 1 |
| Rompré, PP | 1 |
| Meyer, AC | 1 |
| Rahman, S | 1 |
| Charnigo, RJ | 1 |
| Dwoskin, LP | 1 |
| Crabbe, JC | 2 |
| Buckholtz, JW | 1 |
| Treadway, MT | 1 |
| Cowan, RL | 1 |
| Woodward, ND | 1 |
| Li, R | 1 |
| Ansari, MS | 1 |
| Baldwin, RM | 1 |
| Schwartzman, AN | 1 |
| Shelby, ES | 1 |
| Smith, CE | 1 |
| Kessler, RM | 1 |
| Zald, DH | 1 |
| Galloway, GP | 1 |
| Buscemi, R | 1 |
| Coyle, JR | 1 |
| Flower, K | 1 |
| Siegrist, JD | 1 |
| Fiske, LA | 1 |
| Baggott, MJ | 1 |
| Li, L | 1 |
| Polcin, D | 1 |
| Chen, CY | 1 |
| Mendelson, J | 1 |
| Garg, V | 1 |
| Mahdavi, A | 1 |
| Raghavan, S | 1 |
| Hirthler, MA | 1 |
| Yates, JR | 1 |
| Marusich, JA | 1 |
| Beckmann, JS | 1 |
| Kirkpatrick, MG | 1 |
| Gunderson, EW | 1 |
| Johanson, CE | 2 |
| Levin, FR | 1 |
| Foltin, RW | 1 |
| Hart, CL | 1 |
| Silber, BY | 3 |
| Croft, RJ | 3 |
| Downey, LA | 1 |
| Papafotiou, K | 3 |
| Camfield, DA | 1 |
| Stough, C | 2 |
| Feier, G | 1 |
| Valvassori, SS | 1 |
| Lopes-Borges, J | 1 |
| Varela, RB | 1 |
| Bavaresco, DV | 1 |
| Scaini, G | 1 |
| Morais, MO | 1 |
| Andersen, ML | 1 |
| Streck, EL | 1 |
| Quevedo, J | 1 |
| Leri, F | 1 |
| Nahas, E | 1 |
| Henderson, K | 1 |
| Limebeer, CL | 1 |
| Parker, LA | 1 |
| White, NM | 1 |
| Shearer, J | 2 |
| Sherman, J | 1 |
| Wodak, A | 2 |
| van Beek, I | 2 |
| Carnwath, T | 1 |
| Garvey, T | 1 |
| Holland, M | 1 |
| Vanderschuren, LJ | 1 |
| Beemster, P | 1 |
| Schoffelmeer, AN | 1 |
| Fillmore, MT | 1 |
| Marczinski, CA | 1 |
| Galli, G | 1 |
| Wolffgramm, J | 1 |
| George, S | 2 |
| Brebner, K | 2 |
| Ahn, S | 1 |
| Freeman, WM | 1 |
| Amara, SG | 1 |
| Reed, MS | 1 |
| Pohl, J | 1 |
| Kilbey, M | 1 |
| Gatchalian, K | 1 |
| Tancer, M | 1 |
| Stough, CK | 1 |
| Yasar, S | 1 |
| Gaal, J | 1 |
| Justinova, Z | 1 |
| Bergman, J | 1 |
| Lile, JA | 1 |
| Wagner, FP | 1 |
| Ninkovic, J | 1 |
| Folchert, A | 1 |
| Makhankov, YV | 1 |
| Neuhauss, SC | 1 |
| Sillaber, I | 1 |
| Straehle, U | 1 |
| Bally-Cuif, L | 1 |
| Dalley, JW | 1 |
| Lääne, K | 1 |
| Theobald, DE | 1 |
| Peña, Y | 1 |
| Bruce, CC | 1 |
| Huszar, AC | 1 |
| Wojcieszek, M | 1 |
| Everitt, BJ | 1 |
| Robbins, TW | 1 |
| Kliethermes, CL | 1 |
| Kamens, HM | 1 |
| Wu, LT | 1 |
| Pilowsky, DJ | 1 |
| Schlenger, WE | 1 |
| Galvin, DM | 1 |
| McPherson, CS | 1 |
| Featherby, T | 1 |
| Krstew, E | 1 |
| Lawrence, AJ | 1 |
| Jayaram-Lindström, N | 1 |
| Konstenius, M | 1 |
| Eksborg, S | 1 |
| Beck, O | 1 |
| Hammarberg, A | 1 |
| Contreras, M | 1 |
| Ceric, F | 1 |
| Torrealba, F | 1 |
| Novak, SP | 1 |
| Kroutil, LA | 1 |
| Williams, RL | 1 |
| Van Brunt, DL | 1 |
| Sofuoglu, M | 1 |
| Poling, J | 1 |
| Waters, A | 1 |
| Sewell, A | 1 |
| Hill, K | 1 |
| Kosten, T | 1 |
| Robinson, TE | 1 |
| Kolb, B | 1 |
| Ginovart, N | 1 |
| Farde, L | 1 |
| Halldin, C | 1 |
| Swahn, CG | 1 |
| White, R | 1 |
| Braithwaite, RA | 1 |
| Fletcher, PJ | 1 |
| Korth, KM | 1 |
| Subramaniam, S | 1 |
| Marcotte, ER | 1 |
| Srivastava, LK | 1 |
| Mattick, RP | 1 |
| Lewis, J | 1 |
| Hall, W | 1 |
| Dolan, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Multi-Center, Open Label, Evaluation of the Effect and Safety of Lisdexamfetamine in Children Aged 6-12 With Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder[NCT03337646] | Phase 4 | 48 participants (Actual) | Interventional | 2018-09-26 | Active, not recruiting | ||
| Dopaminergic Neuromodulation of Decision Making in Young and Middle-Aged Adults[NCT03512171] | Phase 1 | 65 participants (Actual) | Interventional | 2016-03-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for dextroamphetamine and Amphetamine-Related Disorders
| Article | Year |
|---|---|
Pharmacotherapy for amphetamine dependence: A systematic review.
Topics: Amphetamine; Amphetamine-Related Disorders; Dextroamphetamine; Humans; Medication Adherence; Methylp | 2018 |
Amphetamine, past and present--a pharmacological and clinical perspective.
Topics: Adolescent; Adult; Amphetamine; Amphetamine-Related Disorders; Animals; Attention Deficit Disorder w | 2013 |
Efficacy of psychostimulant drugs for amphetamine abuse or dependence.
Topics: Amphetamine-Related Disorders; Benzhydryl Compounds; Bupropion; Central Nervous System Stimulants; D | 2013 |
[Substitution therapy tested against amphetamine dependence].
Topics: Amphetamine-Related Disorders; Attention Deficit Disorder with Hyperactivity; Central Nervous System | 2016 |
Generation Z: Adolescent Xenobiotic Abuse in the 21st Century.
Topics: Adolescent; Amphetamine-Related Disorders; Cannabinoids; Central Nervous System Stimulants; Designer | 2015 |
Substitution therapy for amphetamine users.
Topics: Amphetamine; Amphetamine-Related Disorders; Dextroamphetamine; Feasibility Studies; Humans | 2002 |
18 trials available for dextroamphetamine and Amphetamine-Related Disorders
| Article | Year |
|---|---|
Utility of a controlled amphetamine withdrawal paradigm among adults who use methamphetamine: A pilot clinical trial.
Topics: Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Dextroamphetamine; Double-B | 2021 |
Sweet taste liking is associated with subjective response to amphetamine in women but not men.
Topics: Adult; Amphetamine-Related Disorders; Animals; Arousal; Behavior, Addictive; Dextroamphetamine; Euph | 2017 |
Neural activation to monetary reward is associated with amphetamine reward sensitivity.
Topics: Adult; Amphetamine-Related Disorders; Brain; Brain Mapping; Central Nervous System Stimulants; Dextr | 2018 |
Associations between sensation seeking and d-amphetamine reinforcement.
Topics: Adult; Amphetamine-Related Disorders; Choice Behavior; Dextroamphetamine; Dose-Response Relationship | 2015 |
Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Cognitive Behav | 2010 |
Are attention lapses related to d-amphetamine liking?
Topics: Adult; Amphetamine-Related Disorders; Attention; Central Nervous System Stimulants; Cross-Over Studi | 2010 |
Subjective and objective effects of the novel triple reuptake inhibitor tesofensine in recreational stimulant users.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Atomoxetine Hydrochloride; Attention; Biogenic Mon | 2010 |
A randomized, placebo-controlled trial of sustained-release dextroamphetamine for treatment of methamphetamine addiction.
Topics: Adult; Amphetamine-Related Disorders; Delayed-Action Preparations; Dextroamphetamine; Double-Blind M | 2011 |
Comparison of intranasal methamphetamine and d-amphetamine self-administration by humans.
Topics: Administration, Intranasal; Adult; Ambulatory Care; Amphetamine-Related Disorders; Cardiovascular Di | 2012 |
The effect of d-methamphetamine on simulated driving performance.
Topics: Administration, Oral; Adult; Amphetamine-Related Disorders; Automobile Driving; Central Nervous Syst | 2012 |
Effects of d-amphetamine on behavioral control in stimulant abusers: the role of prepotent response tendencies.
Topics: Adult; Amphetamine-Related Disorders; Analysis of Variance; Behavior Control; Central Nervous System | 2003 |
Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, meta-chlorophenylpiperazine and placebo.
Topics: Adult; Alcoholism; Amphetamine-Related Disorders; Arousal; Dextroamphetamine; Discrimination Learnin | 2006 |
An evaluation of the sensitivity of the standardised field sobriety tests to detect the presence of amphetamine.
Topics: Accidents, Traffic; Adult; Alcoholic Intoxication; Amphetamine-Related Disorders; Dextroamphetamine; | 2005 |
Oxazepam does not modulate the behavioral effects of d-amphetamine in humans.
Topics: Adult; Amphetamine-Related Disorders; Behavior; Blood Pressure; Central Nervous System Stimulants; D | 2005 |
The acute effects of d-amphetamine and methamphetamine on attention and psychomotor performance.
Topics: Administration, Oral; Adult; Amphetamine-Related Disorders; Attention; Automobile Driving; Dextroamp | 2006 |
Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence.
Topics: Adult; Aging; Amphetamine-Related Disorders; Central Nervous System Stimulants; Cross-Over Studies; | 2008 |
Disulfiram enhances subjective effects of dextroamphetamine in humans.
Topics: Adult; Affect; Alcohol Deterrents; Amphetamine-Related Disorders; Blood Pressure; Cognition; Cross-O | 2008 |
Pilot randomized controlled study of dexamphetamine substitution for amphetamine dependence.
Topics: Adrenergic Uptake Inhibitors; Adult; Amphetamine-Related Disorders; Dextroamphetamine; Feasibility S | 2001 |
50 other studies available for dextroamphetamine and Amphetamine-Related Disorders
| Article | Year |
|---|---|
Nonmedical use of d-Amphetamines and Methylphenidate in Medical Students.
Topics: Adaptation, Psychological; Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; | 2019 |
Reward-enhancing effects of d-amphetamine and its interactions with nicotine were greater in female rats and persisted across schedules of reinforcement.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Animal; Central Nervous System Stimulants; Comorbi | 2021 |
Stress and withdrawal from d-amphetamine alter 5-HT2A receptor mRNA expression in the prefrontal cortex.
Topics: Amphetamine-Related Disorders; Animals; Dextroamphetamine; Gene Expression Regulation; Male; Prefron | 2014 |
Methamphetamine self-administration in humans during D-amphetamine maintenance.
Topics: Adult; Amphetamine-Related Disorders; Delayed-Action Preparations; Dextroamphetamine; Dose-Response | 2014 |
A longitudinal study of self-reported psychopathology in early ecstasy and amphetamine users.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Cohort Studies; Dextroamphetamine; Female; Humans; | 2015 |
A mechanistic study on urine retention in d-amphetamine addicts.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Afferent Pathways; Amidines; Amphetamine-Related Disorders; An | 2014 |
Dopaminergic system dysfunction in recreational dexamphetamine users.
Topics: Amphetamine-Related Disorders; Brain; Brain Mapping; Central Nervous System Stimulants; Dextroamphet | 2015 |
Dopamine and glutamate interaction mediates reinstatement of drug-seeking behavior by stimulation of the ventral subiculum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine-Related Disorders; Animals; Central Nervous System Stimu | 2014 |
Comparison of lisdexamfetamine and dextroamphetamine exposures reported to U.S. poison centers.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Chi-Square Dist | 2015 |
Multivariate analysis of subjective responses to d-amphetamine in healthy volunteers finds novel genetic pathway associations.
Topics: Amphetamine-Related Disorders; Anger; Anxiety; Blood Pressure; Dextroamphetamine; Female; Genome-Wid | 2015 |
D-Amphetamine withdrawal-induced decreases in brain-derived neurotrophic factor in sprague-dawley rats are reversed by treatment with ketamine.
Topics: Amphetamine-Related Disorders; Animals; Brain-Derived Neurotrophic Factor; Central Nervous System St | 2015 |
Effects of dexamphetamine-induced dopamine release on resting-state network connectivity in recreational amphetamine users and healthy controls.
Topics: Amphetamine-Related Disorders; Attention Deficit Disorder with Hyperactivity; Brain; Brain Mapping; | 2016 |
BDNF-Deficient Mice Show Reduced Psychosis-Related Behaviors Following Chronic Methamphetamine.
Topics: Amphetamine-Related Disorders; Animals; Brain-Derived Neurotrophic Factor; Central Nervous System St | 2016 |
The effects of d-govadine on conditioned place preference with d-amphetamine or food reward.
Topics: Amphetamine-Related Disorders; Animals; Berberine Alkaloids; Central Nervous System Stimulants; Cond | 2017 |
A sensitizing d-amphetamine regimen induces long-lasting spinophilin protein upregulation in the rat striatum and limbic forebrain.
Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Corpus Striatum; Dendriti | 2008 |
[Driving under the influence of amphetamine and metamphetamine].
Topics: Amphetamine; Amphetamine-Related Disorders; Automobile Driving; Central Nervous System Stimulants; D | 2009 |
The effect of naltrexone on amphetamine-induced conditioned place preference and locomotor behaviour in the rat.
Topics: Amphetamine-Related Disorders; Animals; Brain; Central Nervous System Stimulants; Choice Behavior; C | 2009 |
Extended access to amphetamine self-administration increases impulsive choice in a delay discounting task in rats.
Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Choice Behavior; Conditio | 2009 |
Attention-deficit/hyperactivity disorder: the road traveled and the road ahead.
Topics: Amphetamine-Related Disorders; Attention Deficit Disorder with Hyperactivity; Central Nervous System | 2009 |
Naltrexone attenuates amphetamine-induced locomotor sensitization in the rat.
Topics: Amphetamine-Related Disorders; Animals; Association Learning; Brain; Central Nervous System Stimulan | 2011 |
Behavioral effects of d-amphetamine in humans: influence of subclinical levels of inattention and hyperactivity.
Topics: Amphetamine-Related Disorders; Attention Deficit Disorder with Hyperactivity; Behavior; Blood Pressu | 2010 |
Acute quetiapine dose-dependently exacerbates anhedonia induced by withdrawal from escalating doses of d-amphetamine.
Topics: Amphetamine-Related Disorders; Animals; Antipsychotic Agents; Behavior, Animal; Central Nervous Syst | 2010 |
Genetics of novelty seeking, amphetamine self-administration and reinstatement using inbred rats.
Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Conditioning, Operant; De | 2010 |
Dopaminergic network differences in human impulsivity.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Autoreceptors; Benzamides; Corpus Striatum; Dextro | 2010 |
Dexamphetamine abuse in an elderly man.
Topics: Aged; Alcoholism; Amphetamine-Related Disorders; Anxiety Disorders; Central Nervous System Stimulant | 2011 |
Change of shift. Of masses and men.
Topics: Amphetamine-Related Disorders; Dextroamphetamine; Emergency Service, Hospital; Female; Humans; Physi | 2011 |
High impulsivity in rats predicts amphetamine conditioned place preference.
Topics: Amphetamine-Related Disorders; Animals; Attention Deficit Disorder with Hyperactivity; Behavior, Ani | 2012 |
Behavioral changes and brain energy metabolism dysfunction in rats treated with methamphetamine or dextroamphetamine.
Topics: Amphetamine-Related Disorders; Amygdala; Animals; Behavior, Animal; Brain; Central Nervous System St | 2012 |
Effects of post-training heroin and d-amphetamine on consolidation of win-stay learning and fear conditioning.
Topics: Amphetamine-Related Disorders; Animals; Avoidance Learning; Behavior, Animal; Central Nervous System | 2013 |
The prescription of dexamphetamine to patients with schizophrenia and amphetamine dependence.
Topics: Adult; Amphetamine-Related Disorders; Antipsychotic Agents; Central Nervous System Stimulants; Dextr | 2002 |
On the role of noradrenaline in psychostimulant-induced psychomotor activity and sensitization.
Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Clonidine; Cocaine; Cocai | 2003 |
Long-term voluntary D-amphetamine consumption and behavioral predictors for subsequent D-amphetamine addiction in rats.
Topics: Aggression; Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Choice Behavi | 2004 |
An audit of the effectiveness of amphetamine isomer ratios as a marker of Dexedrine compliance in amphetamine abusers.
Topics: Adult; Amphetamine-Related Disorders; Amphetamines; Central Nervous System Stimulants; Dextroampheta | 2003 |
Attenuation of d-amphetamine self-administration by baclofen in the rat: behavioral and neurochemical correlates.
Topics: Amphetamine-Related Disorders; Animals; Baclofen; Behavior, Animal; Brain Chemistry; Central Nervous | 2005 |
Distinct proteomic profiles of amphetamine self-administration transitional states.
Topics: Actins; Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Cluster Analysis; | 2005 |
Discriminative stimulus and reinforcing effects of p-fluoro-L-deprenyl in monkeys.
Topics: Amphetamine-Related Disorders; Amphetamines; Animals; Association Learning; Central Nervous System S | 2005 |
Genetic identification of AChE as a positive modulator of addiction to the psychostimulant D-amphetamine in zebrafish.
Topics: Acetylcholine; Acetylcholinesterase; Amphetamine-Related Disorders; Animals; Biological Evolution; B | 2006 |
Enduring deficits in sustained visual attention during withdrawal of intravenous methylenedioxymethamphetamine self-administration in rats: results from a comparative study with d-amphetamine and methamphetamine.
Topics: Amphetamine-Related Disorders; Amphetamines; Animals; Attention; Attention Deficit Disorder with Hyp | 2007 |
Aripiprazole as a potential pharmacotherapy for stimulant dependence: human laboratory studies with d-amphetamine.
Topics: Adult; Amphetamine-Related Disorders; Antipsychotic Agents; Area Under Curve; Aripiprazole; Central | 2006 |
Drug reward and intake in lines of mice selectively bred for divergent exploration of a hole board apparatus.
Topics: Administration, Oral; Amphetamine-Related Disorders; Animals; Central Nervous System Depressants; Ce | 2007 |
Misuse of methamphetamine and prescription stimulants among youths and young adults in the community.
Topics: Adolescent; Adult; Alcoholism; Amphetamine-Related Disorders; Central Nervous System Stimulants; Com | 2007 |
Quantification of phosphorylated cAMP-response element-binding protein expression throughout the brain of amphetamine-sensitized rats: activation of hypothalamic orexin A-containing neurons.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Animal; Brain; Central Nervous System Stimulants; | 2007 |
Inactivation of the interoceptive insula disrupts drug craving and malaise induced by lithium.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Addictive; Behavior, Animal; Cerebral Cortex; Cond | 2007 |
The nonmedical use of prescription ADHD medications: results from a national Internet panel.
Topics: Adolescent; Adult; Alcoholism; Amphetamine-Related Disorders; Appetite Depressants; Attention Defici | 2007 |
Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine.
Topics: Amphetamine-Related Disorders; Animals; Brain Damage, Chronic; Central Nervous System Stimulants; De | 1997 |
Changes in striatal D2-receptor density following chronic treatment with amphetamine as assessed with PET in nonhuman primates.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Animal; Cerebellum; Corpus Striatum; Dextroampheta | 1999 |
Dexamphetamine substitution in the treatment of amphetamine abuse: an initial investigation.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Amphetamine-Related Disorders; Cross-Sectional Stud | 2000 |
Using amphetamine isomer ratios to determine the compliance of amphetamine abusers prescribed dexedrine.
Topics: Amphetamine-Related Disorders; Central Nervous System Stimulants; Dextroamphetamine; Drug Monitoring | 2000 |
RU-24969 disrupts d-amphetamine self-administration and responding for conditioned reward via stimulation of 5-HT1B receptors.
Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Conditioning, Operant; De | 1999 |
Differential changes in synaptic terminal protein expression between nucleus accumbens core and shell in the amphetamine-sensitized rat.
Topics: Amphetamine-Related Disorders; Animals; Antigens, Surface; Blotting, Western; Dextroamphetamine; Dop | 2001 |